Bispecific antibody effective to treat B-cell lymphoma and cell line
The invention provides bispeci? c antibodies With selective cytotoxicity against malignant B-
cells. The bispeci? c anti bodies bind to an effector cell antigen and to a 28/32 kDa …
cells. The bispeci? c anti bodies bind to an effector cell antigen and to a 28/32 kDa …
Bispecific antibody effective to treat B-cell lymphoma and cell line
G Weiner, R Gingrich, BK Link… - US Patent 6,129,914, 2000 - freepatentsonline.com
The invention provides bispecific antibodies with selective cytotoxicity against malignant B-
cells. The bispecific antibodies bind to an effector cell antigen and to a 28/32 kDa …
cells. The bispecific antibodies bind to an effector cell antigen and to a 28/32 kDa …